Associate Professor of Medicine, Massachusetts General Hospital

Infectious Disease

Rochelle Walensky, MD is an expert in the field of Infectious Disease. She attended Johns Hopkins University School of Medicine. Johns Hopkins University School of Medicine is a top medical college. Johns Hopkins University School of Medicine is ranked 3/29 in Research/PrimaryCare. She has 1 awards "Elected Member". Dr. Rochelle Walensky is a published doctor as well. She has 49 publications published. The latest was: Relationship Between Upper Respiratory Tract Influenza Test Result and Clinical Outcomes Among Critically Ill Influenza Patients. Rochelle Walensky is registered with Medicare and accepts Medicare payments.

Publications

---

• Impact of rapid screening for discontinuation of methicillin-resistant Staphylococcus aureus contact precautions.
• Peripheral blood eosinophilia and hypersensitivity reactions among patients receiving outpatient parenteral antibiotics.
• Housestaff Knowledge Related to Urinary Catheter Use and Catheter-Associated Urinary Tract Infections.
• The clinical role and cost-effectiveness of long-acting antiretroviral therapy.
• The Lifetime Medical Cost Savings From Preventing HIV in the United States.
• Lifetime medical costs of knee osteoarthritis management in the United States: impact of extending indications for total knee arthroplasty.
• The cost-effectiveness of genotype testing for primary resistance in Brazil.
• The Linkage Outcomes of a Large-scale, Rapid Transfer of HIV-infected Patients From Hospital-based to Community-based Clinics in South Africa.
• The Clinical and Economic Impact of Point-of-Care CD4 Testing in Mozambique and Other Resource-Limited Settings: A Cost-Effectiveness Analysis.
• HIV testing rates, prevalence, and knowledge among outpatients in Durban, South Africa: Time trends over four years.
• Clinic-based routine voluntary HIV testing in a refugee settlement in Uganda.
• Linkage to care following community-based mobile HIV testing compared with clinic-based testing in Umlazi Township, Durban, South Africa.
• Individualizing the WHO HIV and infant feeding guidelines: optimal breastfeeding duration to maximize infant HIV-free survival.
• HIV Prevention in Clinical Care Settings: 2014 Recommendations of the International Antiviral Society-USA Panel.
• Clinical impact and cost-effectiveness of making third-line antiretroviral therapy available in sub-Saharan Africa: A model-based analysis in Côte d'Ivoire.
• Global Health Training in US Graduate Psychiatric Education.
• Integrating social contact and environmental data in evaluating tuberculosis transmission in a South African township.
• The survival benefits of antiretroviral therapy in South Africa.
• Concordance of PCR and culture from nasal swabs for MRSA in setting of concurrent anti-staphylococcal antibiotics.
• US medical specialty global health training and the global burden of disease.
• Cost-effectiveness of HIV treatment as prevention in serodiscordant couples.
• Combination HIV prevention: the value and interpretation of mathematical models.
• Disease-modifying drugs for knee osteoarthritis: can they be cost-effective?
• High frequency of hypothalamic-pituitary-adrenal axis dysfunction after local corticosteroid injection in HIV-infected patients on protease inhibitor therapy.
• The Acceptability and Feasibility of Routine Pediatric HIV Testing in an Outpatient Clinic in Durban, South Africa.
• Discontinuation of Contact Precautions for Methicillin-Resistant Staphylococcus aureus (MRSA): A Randomized Controlled Trial Comparing Passive and Active Screening wit...
• Risk Factors for Late-Stage HIV Disease Presentation at Initial HIV Diagnosis in Durban, South Africa.
• The clinical and economic impact of genotype testing at first-line antiretroviral therapy failure for HIV-infected patients in South Africa.
• Cost-effectiveness of World Health Organization 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe.
• Missed opportunities: refusal to confirm reactive rapid HIV tests in the emergency department.
• Economic savings versus health losses: the cost-effectiveness of generic antiretroviral therapy in the United States.
• The cost-effectiveness of pre-exposure prophylaxis for HIV infection in South African women.
• HIV preexposure prophylaxis in the United States: impact on lifetime infection risk, clinical outcomes, and cost-effectiveness.
• Antiretroviral drugs for preventing mother-to-child transmission of HIV in sub-Saharan Africa: balancing efficacy and infant toxicity.
• The HIV Cure Research Agenda: The Role of Mathematical Modelling and Cost-Effectiveness Analysis.
• Point-of-Care CD4 Testing to Inform Selection of Antiretroviral Medications in South African Antenatal Clinics: A Cost-Effectiveness Analysis.
• HIV Cure Strategies: How Good Must They Be to Improve on Current Antiretroviral Therapy?
• Quantification of shared air: a social and environmental determinant of airborne disease transmission.
• Effectiveness of first-line antiretroviral therapy in the IPEC cohort, Rio de Janeiro, Brazil.
• Development, Calibration and Performance of an HIV Transmission Model Incorporating Natural History and Behavioral Patterns: Application in South Africa.
• Natural history of colonization with methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE): a systematic review.
• Diagnostic accuracy of a point-of-care urine test for tuberculosis screening among newly-diagnosed hiv-infected adults: a prospective, clinic-based study.
• Mobile HIV Screening in Cape Town, South Africa: Clinical Impact, Cost and Cost-Effectiveness.
• Validation and Calibration of a Computer Simulation Model of Pediatric HIV Infection.
• Routine HIV Screening in Portugal: Clinical Impact and Cost-Effectiveness.
• Factors Associated with Self-Reported Repeat HIV Testing after a Negative Result in Durban, South Africa.
• The Cost-effectiveness and Budget Impact of 2-Drug Dolutegravir-Lamivudine Regimens for the Treatment of HIV Infection in the United States.
• Relationship Between Upper Respiratory Tract Influenza Test Result and Clinical Outcomes Among Critically Ill Influenza Patients.

Schools

---

• Johns Hopkins University School of Medicine

• Johns Hopkins Hospital

• Mass Genl HospBrigham and Women39s Hospital

Doctors Specialties

---

• Infectious Disease Medicine
• Infectious Disease

Accepted Insurances

---

Awards

---

• Elected Member

Education

---

• Massachusetts General Hospital
• Johns Hopkins University
• Johns Hopkins University School of Medicine

Hospital

---

• Brigham and Women's Hospital
• Massachusetts General Hospital

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1447240981
Last Name Of The Provider	WALENSKY
First Name Of The Provider	ROCHELLE
View All

Similar Doctors

---

	Dr. Aimalohi A. Ahonkhai, MD This Doctor is OpenDoctor Recommended.
	Dr. Alissa J. Wright, MD This Doctor is OpenDoctor Recommended.
	Dr. Mathias Lichterfeld, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Sabina A. Islam, MD This Doctor is OpenDoctor Recommended.
	Dr. Joseph B. El-Khoury, MD This Doctor is OpenDoctor Recommended.
	Dr. Michael R. Wessels, MD This Doctor is OpenDoctor Recommended.
	Dr. Arthur Y. Kim, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Kenneth E. Sands, MD This Doctor is OpenDoctor Recommended.
	Dr. Chen S. Tan, MD This Doctor is OpenDoctor Recommended.
	Dr. Christopher F. Rowley, MD This Doctor is OpenDoctor Recommended.
	Dr. Rachel P. Baden, MD This Doctor is OpenDoctor Recommended.
	Dr. Richa Tandon, MD This Doctor is OpenDoctor Recommended.
	Dr. Donald M. Thea, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Benjamin P. Linas, MD This Doctor is OpenDoctor Recommended.
	Dr. Robin R. Ingalls, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog